Maxim Group downgraded bluebird bio (NASDAQ: BLUE) from Buy to Hold.Analyst Jason McCarthy commented:bluebird's valuation has climbed since 4Q16 (CAR-T ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE